VanPelt, Jamie
Shurina, Ben A.
Ramelot, Theresa A.
Bonomo, Robert A.
Page, Richard C. http://orcid.org/0000-0002-3006-3171
Funding for this research was provided by:
National Institute of General Medical Sciences (R35GM128595)
National Institute of Allergy and Infectious Diseases (R01AI100560, R01AI063517, R21AI114508, R01AI072219)
Article History
Received: 22 September 2018
Accepted: 11 December 2018
First Online: 14 December 2018
Compliance with ethical standards
:
: The corresponding author (RCP) is the recipient of a research contract from Allecra Therapeutics to study KPC-2. The authors RCP and RAB are the co-recipients of a research contract (MISP #57394) from Merck & Co. to study inhibition of KPC-2.